Glaxo Smith Kline R&D
Glaxo Smith Kline R&D, Glaxo Smith Kline, is connected in UK Power Networks's Embedded Capacity Register of 14 Oct 2026 at 4 MW, grid supply point Rye House.
- Customer
- Glaxo Smith Kline
- Status
- Connected
- Capacity
- 4 MW
- Technology
- Other, Solar (Other)
- Flexible connection
- No
- Grid supply point
- Rye House
- Bulk supply point
- Rye House Grid 33kV
- Point of connection
- Glaxo Primary 11kV
- Voltage
- 11 kV
- Date connected
- 8 Feb 2011
- In a connection queue
- No
- Row last updated by the DNO
- 15 Jan 2021
- Licence area
- EPN
- Address
- Park Road, Ware
- Postcode
- SG12 0DP
- Export MPAN
- 1030074763118
A distribution project is the rows of one DNO’s Embedded Capacity Register that agree on licence area, customer site, grid supply point and customer; no DNO publishes a reference on every row. Each row’s capacity is the DNO’s own figure for that row and rows are never summed. Accepted to connect is the DNO’s status; a flexible (ANM) connection’s capacity is not firm. A target energisation date is as published, a planned date. Distribution MW are never added to TEC.
Source
- UK Power Networks Embedded Capacity Register (1 MW and over), UK Power Networks, publication of 14 Oct 2026. CC BY 4.0, UK Power Networks.